Yuvraj

Abbott Park, Illinois-Reata Pharmaceuticals and Abbott today announced data from a Phase 2b study which suggests that bardoxolone methyl, an investigational treatment for chronic...

Reata Pharmaceuticals and Abbott announced data from a Phase 2b study which suggests that bardoxolone methyl, an investigational treatment for chronic kidney disease (CKD),...

Antares Pharma, Inc., a leader in self-injection drug delivery technology, announced the latest advancement in its proprietary line of VIBEX(TM) auto-injectors. ...

Pfizer Inc.announced that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma...

{japopup type="iframe" content="https://www.worldpharmatoday.com/images/stories/reports1.png" title="Graph View" width="795" height="537"}{/japopup} {japopup type="iframe" content="https://www.worldpharmatoday.com/images/stories/reports1.JPG" title="Detail View" width="882" height="169"}{/japopup}

Novartis presented today a strategic overview of the company's diversified healthcare portfolio which creates the potential for future sustainable growth. The company's focused healthcare...

Britannia Industries Limited, one of India’s leading Food companies, has over the last 2 years demonstrated significant initiatives in the Health and Wellness space....